Short-latency afferent inhibition in patients with Parkinson's disease and freezing of gait

被引:24
作者
Picillo, Marina [1 ,2 ,3 ,4 ]
Dubbioso, Raffaele [5 ]
Iodice, Rosa [5 ]
Iavarone, Alessandro [6 ]
Pisciotta, Chiara [5 ]
Spina, Emanuele [5 ]
Santoro, Lucio [5 ]
Barone, Paolo [1 ]
Amboni, Marianna [1 ,7 ]
Manganelli, Fiore [5 ]
机构
[1] Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Dept Med & Surg, I-84131 Salerno, Italy
[2] Univ Toronto, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada
[3] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada
[4] Univ Toronto, Div Neurol, Toronto, ON, Canada
[5] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, I-80131 Naples, Italy
[6] AORN Osped Colli, CTO Hosp, Neurol & Stroke Unit, Naples, Italy
[7] IDC Hermitage Capodimonte, Naples, Italy
关键词
Freezing; Gait; Cholinergic activity; PPN; SAI; Cognition; TMS; Parkinson's disease; CENTRAL CHOLINERGIC CIRCUITS; MILD COGNITIVE IMPAIRMENT; PEDUNCULOPONTINE NUCLEUS; DIAGNOSTIC-CRITERIA; EXECUTIVE FUNCTIONS; MOTOR CORTEX; STIMULATION; MOVEMENT; DEMENTIA; DISORDER;
D O I
10.1007/s00702-015-1428-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson's disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG-). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG-. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG- had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (> 72 %). FOG+ presented poorer executive and visuospatial performances as compared to FOG-. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.
引用
收藏
页码:1533 / 1540
页数:8
相关论文
共 39 条
[1]   Freezing of gait and executive functions in patients with Parkinson's disease [J].
Amboni, Marianna ;
Cozzolino, Autilia ;
Longo, Katia ;
Picillo, Marina ;
Barone, Paolo .
MOVEMENT DISORDERS, 2008, 23 (03) :395-400
[2]   Cognitive Contributions to Gait and Falls: Evidence and Implications [J].
Amboni, Marianna ;
Barone, Paolo ;
Hausdorff, Jeffrey M. .
MOVEMENT DISORDERS, 2013, 28 (11) :1520-1533
[3]   A Two-Year Follow-Up Study of Executive Dysfunctions in Parkinsonian Patients with Freezing of Gait at On-State [J].
Amboni, Marianna ;
Barone, Paolo ;
Picillo, Marina ;
Cozzolino, Autilia ;
Longo, Katia ;
Erro, Roberto ;
Iavarone, Alessandro .
MOVEMENT DISORDERS, 2010, 25 (06) :800-802
[4]   Pedunculopontine nucleus Functional organization and clinical implications [J].
Benarroch, Eduardo E. .
NEUROLOGY, 2013, 80 (12) :1148-1155
[5]   Extra-nigral Pathological Conditions Are Common in Parkinson's Disease With Freezing of Gait: An In Vivo Positron Emission Tomography Study [J].
Bohnen, Nicolaas I. ;
Frey, Kirk A. ;
Studenski, Stephanie ;
Kotagal, Vikas ;
Koeppe, Robert A. ;
Constantine, Gregory M. ;
Scott, Peter J. H. ;
Albin, Roger L. ;
Mueller, Martijn L. T. M. .
MOVEMENT DISORDERS, 2014, 29 (09) :1118-1124
[6]   Short latency afferent inhibition in Parkinson's disease patients with dementia [J].
Celebi, Ozlem ;
Temucin, Cagri Mesut ;
Elibol, Bulent ;
Saka, Esen .
MOVEMENT DISORDERS, 2012, 27 (08) :1052-1056
[7]   Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease [J].
Devos, David ;
Defebvre, L. ;
Bordet, R. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 (04) :407-421
[8]   In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias [J].
Di Lazzaro, V ;
Pilato, F ;
Dileone, M ;
Saturno, E ;
Oliviero, A ;
Marra, C ;
Daniele, A ;
Ranieri, F ;
Gainotti, G ;
Tonali, PA .
NEUROLOGY, 2006, 66 (07) :1111-1113
[9]   Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans [J].
Di Lazzaro, V ;
Oliviero, A ;
Saturno, E ;
Dileone, M ;
Pilato, F ;
Nardone, R ;
Ranieri, F ;
Musumeci, G ;
Fiorilla, T ;
Tonali, P .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 564 (02) :661-668
[10]   Normal or enhanced short-latency afferent inhibition in Parkinson's disease? [J].
Di Lazzaro, V ;
Oliviero, A ;
Pilato, F ;
Saturno, E ;
Dileone, M ;
Bentivoglio, AR ;
Tonali, PA .
BRAIN, 2004, 127 :E8-U1